Publications by authors named "M Anselmino"

This systematic review aims to evaluate the current evidence regarding safety and efficacy of magnetic sphincter augmentation (MSA) for the treatment of gastroesophageal reflux disease (GERD) after laparoscopic sleeve gastrectomy (LSG). Conversion to Roux-en-Y gastric bypass (RYGB) carries the risk of surgical and metabolic complications and may be contraindicated in patients with normalized or near-normalized body mass index. The LINX™ procedure aims to restore LES competency and to repair the crura.

View Article and Find Full Text PDF

Atrial high-rate episodes (AHREs) and subclinical atrial fibrillation (AF) are frequently registered in asymptomatic patients with cardiac implantable electronic devices (CIEDs) and insertable cardiac monitors (ICMs). While an increased risk of thromboembolic events (e.g.

View Article and Find Full Text PDF
Article Synopsis
  • Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically semaglutide, show cardiovascular benefits and may reduce the incidence of atrial fibrillation (AF) in high-risk patients.
  • A meta-analysis of 10 randomized clinical trials involving 12,651 patients revealed a 42% reduction in the risk of AF with semaglutide compared to placebo during an average follow-up of 68 months.
  • The study found no significant differences in AF risk reduction based on the route of administration (oral or subcutaneous), as well as no influence from baseline characteristics like diabetes status or BMI.
View Article and Find Full Text PDF

Background: The combination of highly localized impedance (LI) and contact force (CF) may improve tissue characterization and lesion prediction during radiofrequency (RF) pulmonary vein isolation (PVI) in patients with atrial fibrillation (AF).

Objective: We report the outcomes of our acute and long-term clinical evaluation of CF-LI-guided PVI in consecutive AF ablation cases from an international multicenter clinical setting.

Methods: Three hundred twenty-four consecutive patients from 20 European centers undergoing RF catheter ablation with the Stablepoint™ catheter were enrolled in the CHARISMA registry.

View Article and Find Full Text PDF